- Home
- Programs and Groups
- Shared Resources
- Faculty
- Clinical Trials
- Tumor Registry
- Education
- About DCI
Quick Links
Pediatric Clinical Trials - Pediatric Leukemia/MDS
If you would like to inquire about all open trials, please contact 919-684-3401.
Items 1 - 7 of 7
Items 1 - 7 of 7
AALL06N1 A Study of Neurocognitive Function in Children Treated for ALL
Principal Investigator: Susan Kreissman
Phase: N/A
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: N/A
Phone: 919-684-3401
AALL08B1 Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Principal Investigator: Susan Kreissman
Phase: N/A
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: N/A
Phone: 919-684-3401
A Phase III Study of Risk Directed Therapy for Infants with Acute Lympoblastic Leukemia (ALL);Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibitition (CEP-701, Lestaurtinib; IND76431; NSC#617807)
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
AALL0433 Intensive Treatment for Intermediate-Risk Relapse of Childhood B-precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
AALL0434 Intensified Methotrexate, Nelarabine Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
AALL0932 Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
ACCL0933 A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
